The original Bicycle Music Festival took place on Saturday, June 22, 2013 at the Pioneer Log Cabin Meadow in Golden Gate Park in San Francisco, California. The event featured people riding and sharing their love of bicycles, playing music and open invitation partying from noon till 9PM. A bike parade with all the participants started the event off from 22nd Street to Bartlett.
Transvaginal Mesh Injury Lawsuits: Next C.R. Bard Trial Slated for Dec. 3, Rottenstein Law Group LLP Reports
The next C.R. Bard transvaginal mesh trial is scheduled for Dec. 3 in the U.S. District Court in West Virginia, according to court documents. The Rottenstein Law Group LLP, which represents clients in transvaginal mesh injury lawsuits, reports on updates related to Bard mesh trials, in addition to offering a brief rundown of the multimillion dollar vaginal mesh verdicts to date.
DePuy ASR Lawsuit Settlement News: Johnson & Johnson Agrees to Settle for at Least $2.5 Billion, Notes Rottenstein Law Group LLP
Johnson & Johnson and its subsidiary DePuy Orthopaedics agreed Nov. 19 to a DePuy ASR hip settlement of at least $2.5 billion, according to news reports. The Rottenstein Law Group LLP, a metal-on-metal hip implant law firm, notes that those who underwent revision surgery will be eligible for a settlement, but settlement is not required.
There are six federal case consolidations in U.S. District Court for the Southern District of West Virginia for as many major mesh manufacturers, and bellwether trials have been scheduled for most of them, according to court documents. The Rottenstein Law Group LLP, which represents clients in vaginal mesh lawsuits, notes that the next trial scheduled, which involves C.R. Bard, is coming up on Dec. 3.
DePuy ASR Settlement Update: Rottenstein Law Group LLP Comments on $4 Billion DePuy Hip Settlement News
Johnson & Johnson subsidiary DePuy Orthopaedics will reportedly offer $4 billion in DePuy settlements to resolve thousands of DePuy ASR hip lawsuits in state and federal courts, according to a Nov. 12 Bloomberg Businessweek article.* The Rottenstein Law Group LLP notes that part of the agreement says that future patients who find their hip implants are allegedly defective will still be able to sue, meaning that the value of the settlement could increase.
Bergen County District Court in New Jersey has deemed a DePuy ASR hip lawsuit “resolved” and removed the matter from its trial calendar, according to court documents. The Rottenstein Law Group LLP, which maintains a comprehensive DePuy settlements informational website, notes that if the case has settled out of court then it will join a growing list of ASR lawsuits similarly resolved.
DePuy ASR Hip Lawsuit News: Settlement Reached in California Hip Case, Rottenstein Law Group LLP Reports
Johnson & Johnson subsidiary DePuy Orthopaedics has agreed to settle a DePuy ASR hip lawsuit before what would have been the first bellwether trial in a California state court consolidation of ASR cases. The Rottenstein Law Group LLP, which maintains the hip implant informational website http://www.depuysettlements.com, notes that the settlement joins a growing list of current and potential ASR settlements.
Years of research and development have led to the realization of the Da Vinci surgical system that is now being used to help surgeons perform complex surgeries in operating rooms, news reports say, but there are still many hospitals that are unable to obtain it because of the steep price. The price tag of each of the machine costs over a million dollars and the needed system upgrades to compensate in the areas lacking may also steer the price much higher, according to the study entitled “Robotic Surgery: A Current Perspective.” The study was published in the Annals of Surgery to review the history and development of robotics and how it is being used today in modern surgery.
Although the use of robots in operating rooms is seen as great advancement in health care, there are many critics to the use of the Da Vinci surgical system. The massive marketing of the popular robotic assistant downplays the risks but highlights the benefits, analysts say. The cost of the machine alone may make hospitals think twice and many times before acquiring it, especially small rural county hospitals. For big and famous hospitals, this may be purchased without any difficulty and may be seen as an investment since it is the first of its kind and there are several benefits to using it.
Hospitals that were able to purchase it may have some edge against other hospitals that do not have the robotic assistant yet. Some patients who have heard about this new innovation in health care flocked hospitals in search for it, medical industry observers say, because of the “wow” factor that the surgery entails. However, due to the high price of these machines, the cost for the surgeries performed may also increase and much higher than the regular laparoscopic surgeries.
The steep learning curve for the use of these machines also makes it hard for most surgeons to get themselves started. Specialized trainings are given to surgeons who are interested in gaining trial and proficiency but the actual surgical experience is largely different when compared to the trainings conducted by the manufacturer. Several institutions other than the manufacturer also offer trainings to health care providers. Different packages are offered and health care professionals are required to pay for these trainings. Critics believe that the overall cost of the machine, trainings and changes in the operating room to accommodate the machines will all be shouldered by the patients who will be using this new innovation. This site offers more information on the Da Vinci surgical system.